Search Resources
Search Resources

New resource added to CPPN

0 November 12, 2017

An article in US News & World Report describes the fast-growing field of personalized medicine and how it can help doctors pinpoint optimal ways to treat illnesses and keep patients healthier.

Posted in Uncategorized by Rachel Mills
0 August 30, 2017

A Royal Society Pharmaceutical publication recognizes the important role of pharmacists in delivering genomic medicine.

Posted in Uncategorized by Rachel Mills
0 August 11, 2017

Pharmacogenomics is a hot topic of late, with multiple news reports and online stories of the purpose and benefits of pharmacogenetic testing. From July, a story from Huffington Post about integration of pharmacogenetic testing results into an electronic health record system to alert physicians of the results when prescribing new medications.   http://www.huffingtonpost.com/entry/study-pioneers-use-of-pharmacogenomic-data-in-electronic_us_59653fb6e4b09be68c0055f3

Posted in Uncategorized by Rachel Mills
0 August 11, 2017

This week, NBC News shared the story of Sarah Ellis who spent years trying different medications to treat her depression. Finally, her doctor decided to try pharmacogenetic testing to identify a drug that could work for her. Thanks to that test, the doctor recognized that Ellis was sensitive to many common drugs used to treat depression and prescribed a different drug at a lower dose. The report also describes the Genefolio test, developed by Avera Institute for Human Genetics in Sioux Falls, South Dakota.   http://www.nbcnews.com/health/mental-health/finding-right-medication-gene-test-may-help-treat-depression-n782781

Posted in Uncategorized by Rachel Mills
0 February 6, 2017

Posted in Uncategorized by Rachel Mills
0 January 31, 2017

Following its successful launch at the University of Pittsburgh last fall, the National Association of Chain Drug Stores (NACDS) in partnership with the University of Pittsburgh School of Pharmacy will expand the Test2Learn Community-Based Pharmacogenomics Certificate Program to three new locations: Duke University (Durham, NC) (Apr 10-11), Chapman University’s School of Pharmacy (Irvine, CA)., and The Ohio State University (Columbus, OH). NACDS and the University of Pittsburgh School of Pharmacy adapted Test2Learn from an innovative University platform that enables students to learn by using real genetic data in highly-interactive exercises. The certificate program is comprised of online home study modules and in-person live components, including an optional activity for learners to undergo personal genomic testing. In addition to the in-person aspect of the program, pharmacist participants will also learn how to administer the training to others during the “train-the-trainer” component of the course. Please see the NACDS site for further information and to register.

Posted in Uncategorized by Rachel Mills
0 November 7, 2016

Researchers at Columbia University recently published research in Pharmacogenomics and Personalized Medicine indicating that pharmacogenetic (PGx) markers are a risk factor associated with frequent hospitalizations in older adults taking multiple medications. Finkelstein et al found that more than one major PGx variant was identified in half of cases of hospitalized adults. And though drug-gene interactions were identified in cases of hospitalizations, zero drug-gene interactions were identified in the control group of older adults taking multiple meds without hospitalization. As such, findings indicate that PGx testing may be beneficial to identify these drug-gene interactions in order to adjust drug or dose. A nice overview of the study is available at ClinicalOmics. Read the full text of Finkelstein et al “Pharmacogenetic polymorphism as an independent risk factor for frequent hospitalizations in older adults with polypharmacy: a pilot study” here.

Posted in Uncategorized by Rachel Mills
0 August 16, 2016

In the “Directions in Pharmacy” section of the July 2016 issue of Pharmacy Times, researchers from UCSF review the science and history of pharmacogenetics with a discussion of the clinical utility of PGx testing in obviating the prevalence of medication non-response and adverse effects as determined by individual variation in genetically mediated response to medications. Visit the Pharmacy Times site to read more.

Posted in Uncategorized by Rachel Mills
0 August 2, 2016

Understanding the basics of pharmacogenomics and how it differs from other genetic tests can help you decide whether or not these tests could be a useful tool for you and your doctor.

Mark Dunnenberger

Mark Dunnenberger, PharmD, a Senior Clinical Specialist in pharmacogenomics at NorthShore Center for Personalized Medicine shares a list of seven things all patients should know about pharmacogenetics. In this USNews blog post, Dr. Dunnenberger breaks down the benefits and limitations of PGx testing. See the complete list of “things to know” here: http://health.usnews.com/health-news/patient-advice/articles/2016-08-01/7-things-to-know-about-pharmacogenomics 

Posted in Uncategorized by Rachel Mills